These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 17370621)
1. [Genetic polymorphisms of human ABC transporter ABCG2: Porphyria risk and ER quality control]. Wakabayashi K; Tamura A; Ishikawa T Seikagaku; 2007 Feb; 79(2):151-7. PubMed ID: 17370621 [No Abstract] [Full Text] [Related]
2. Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation. Wakabayashi-Nakao K; Tamura A; Furukawa T; Nakagawa H; Ishikawa T Adv Drug Deliv Rev; 2009 Jan; 61(1):66-72. PubMed ID: 19111842 [TBL] [Abstract][Full Text] [Related]
3. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919 [TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995 [TBL] [Abstract][Full Text] [Related]
5. The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy. Ishikawa T Adv Drug Deliv Rev; 2009 Jan; 61(1):1-2. PubMed ID: 19124052 [No Abstract] [Full Text] [Related]
6. [Functional SNPs of the breast cancer resistance protein (ABCG2) gene altering the pharmacokinetics/pharmacodynamics of anticancer agents]. Sugimoto Y Seikagaku; 2005 Sep; 77(9):1196-200. PubMed ID: 16241009 [No Abstract] [Full Text] [Related]
7. ABCG2 -- a transporter for all seasons. Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic importance of ABCG2. Cusatis G; Sparreboom A Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776 [TBL] [Abstract][Full Text] [Related]
11. [Drug resistance mediated by ABC transporters]. Yoshikawa M; Ito A; Ishikawa T; Ikegami Y Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312 [TBL] [Abstract][Full Text] [Related]
12. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing]. Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study. Kopp TI; Andersen V; Tjonneland A; Vogel U Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419 [TBL] [Abstract][Full Text] [Related]
14. Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays. Hegedus C; Szakács G; Homolya L; Orbán TI; Telbisz A; Jani M; Sarkadi B Adv Drug Deliv Rev; 2009 Jan; 61(1):47-56. PubMed ID: 19135105 [TBL] [Abstract][Full Text] [Related]
15. Methods to examine the impact of nonsynonymous SNPs on protein degradation and function of human ABC transporter. Ishikawa T; Wakabayashi-Nakao K; Nakagawa H Methods Mol Biol; 2013; 1015():225-50. PubMed ID: 23824860 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. Bruhn O; Cascorbi I Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314 [TBL] [Abstract][Full Text] [Related]
17. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms modify the transporter activity of ABCG2. Morisaki K; Robey RW; Ozvegy-Laczka C; Honjo Y; Polgar O; Steadman K; Sarkadi B; Bates SE Cancer Chemother Pharmacol; 2005 Aug; 56(2):161-72. PubMed ID: 15838659 [TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Mizuarai S; Aozasa N; Kotani H Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175 [TBL] [Abstract][Full Text] [Related]